Baranowski becomes CEO at Avalyn

Avalyn Pharma Inc. hired Lyn Baranowski to succeed CEO Bruce Montgomery, who founded the pulmonary disease company. Baranowski was COO at Altavant Sciences Inc., a rare respiratory disease company, and previously held business development, marketing and public affairs roles at Novartis AG (SIX:NOVN; NYSE:NVS).

Joseph Elassal became CMO at Ankyra Therapeutics Inc., a cancer company developing targeted immunotherapies. Elassal, who was senior medical director of global medical affairs in oncology at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), succeeds Howard Kaufman, who was recently promoted to president and CEO. ...